article thumbnail

The EU HTA regulation: a new frontier for access to innovative technologies

European Pharmaceutical Review

1 The regulation is the culmination of a long debate between European Union (EU) Member States and health sector stakeholders, triggered by joint actions such as European Network for Health Technology Assessment (EUnetHTA) and formalised through the European Commission (EC)’s proposal in January 2018. European Commission; 2018. Lorgelly PK.,

article thumbnail

Voice is Becoming the Loudest Tool in the Exam Room

PM360

The line from the 2011 Pixar “Cars” sequel (trust me, as a parent of two, I have seen it countless times) points to the practical implication for voice technology. Health systems are signing off on network-wide solutions that use AI companions to record conversations, compile EHR notes, and even order tests and prescriptions.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Are timely access and robust safety mutually exclusive?

pharmaphorum

A European Federation of Pharmaceutical Industries and Associations (EFPIA) report published earlier this year, for example, compared the timelines of six regulatory agencies between 2011 and 2020. It found the EMA “lagged behind” most, with a median approval time in 2020 of more than 400 days.

Safety 98
article thumbnail

Top 12 Healthcare Technology Start-ups To Know

Medico Reach

Founder: Jacob Sattelmair Year of establishment: 2011 Headquarters: Boston, Massachusetts. They have developed mobile apps that are meant to: Provide patients with clinical and emotional support in crises Create a network of clinics and facilities to help patients find doctors easily.

article thumbnail

Using RWE in rare disease drug development: effective innovations with historical controls

European Pharmaceutical Review

11 have recently conducted an analysis of international HTA submissions from 2011-2019 to determine the acceptability of single arm clinical studies and ECs as part of the drug reimbursement process. He is a member of the EMEA’s European Network of Centres for Pharmacoepidemiology and Pharmacovigilance ( www.encepp.eu ). Patel et al.

article thumbnail

Patient centricity 101: How to create content that REALLY communicates

pharmaphorum

According to the European Commission and NIHR Clinical Research Network, between 2007 and 2011, delays for launching clinical trials rose by 90%. And with approximately one third of the clinical trial timeline spent in patient recruitment, delays in launching clinical trials will increase costs and drain resources.

article thumbnail

The Caregiver Vertical: How Pharma Engages

Pharma Marketing Network

Sunny White is an Editorial Advisory Board member for the Pharma Marketing Network with unique insights into how important caregivers are to the HCP/patient relationship and overall health outcomes. Becoming “the caregiver champion” positions pharma to better understand and contribute to this important member of the frontline care team.

Pharma 98